So much energy is going into developing effective weight loss pills, while hundreds of lifesaving medications remain in shortage.
Health and Social Policy
Posted inHealth and Social Policy
The Obscure NIH Official Blocking Lower Drug Prices
Mark Rohrbaugh, a mid-level staffer at the National Institutes of Health, has consistently blocked the use of march-in rights to seize patents on high-cost drugs.
Posted inHealth and Social Policy
Can Digital Credentials Boost Enrollment in Social Welfare Programs?
A new study says yes, but barriers will persist.
Posted inHealth and Social Policy
In North Carolina, the Uninsured Say Medicaid Expansion Will Be Life-Changing
After years of contentious battles amid a rural health crisis, the state voted to expand the program.
Posted inHealth and Social Policy
Merck Says Negotiating Drug Prices Is Unconstitutional
The Inflation Reduction Act took minor steps against Big Pharma price-gouging. Merck is outraged.
Posted inHealth and Social Policy
How Big Pharma Rigged the Patent System
Drug patents are supposed to expire in 20 years. Thanks to legal trickery, though, it usually takes a lot longer than that.
Posted inHealth and Social Policy
The Looming Child Care Cliff
In 2021, Congress issued grants to stabilize the child care system. Now the money is about to run out.
Posted inHealth and Social Policy
Hospitals’ Bid for Quick Cash Leaves Patients Worse Off
Medical credit cards shift the burden of medical financing onto unsuspecting consumers who could have qualified for other means of payment.
Posted inHealth and Social Policy
Quackonomics
Medical Properties Trust spent billions buying community hospitals in bewildering deals that made private equity rich and working-class towns reel.
Posted inHealth and Social Policy
So Long but Not Farewell to Envision
The private equity–owned ER doctor practice, now headed to bankruptcy, was one of the defining companies of 21st-century American medicine.
